More than 70% of users report side effects ranging from nausea and bloating to more severe complications like pancreatitis, gallbladder disease, and even mental health concerns such as suicidal ideation or disordered eating
The scientific evidence supporting their ability to raise GLP-1 levels or lead to substantial weight loss is limited at best
Limitations and future work Due to the smaller brains of mice versus rats and the 9.4 T vs
However, new research has found that up to one in 10 people may have genetic variants that make them resistant to the effects of these drugs
Reported Benefits Driving GLP-1 Microdosing As interest in GLP-1 microdosing continues to grow, certain themes appear repeatedly in patient conversations, online communities, and telehealth discussions
The fact that retatrutide passed its Phase 1 and Phase 2 trials means researchers deemed it safe enough for large-scale human testing